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Aims. Evaluation of bariatric surgery as secondary prevention in obese patients with ischemic heart disease (IHD). Methods.
Analysis of data from 4047 subjects in the Swedish Obese Subjects (SOSs) study. Thirty-ﬁve patients with IHD are treated with
bariatric surgery (n = 21) or conventional treatment (n = 14). Mean follow-up is 10.8 years. Results. Bariatric surgery resulted in
sustained weight loss during the study period. After 2 years, the surgery group displayed signiﬁcant reductions in cardiovascular
risk factors, relief from cardiorespiratory symptoms, increments in physical activity, and improved quality of life. After 10 years,
recovery from hypertension, diabetes, physical inactivity, and depression was still more common in the surgery group. There were
no signs of increased cardiovascular morbidity or mortality in the surgery group. Conclusion. Bariatric surgery appears to be a safe
and feasible treatment to achieve long-term weight loss and improvement in cardiovascular risk factors, symptoms, and quality of
life in obese subjects with IHD.
1.Introduction
Obesity, togetherwithassociatedclustering ofcardiovascular
risk factors, is a strong promoter for cardiovascular disease
morbidity and mortality [1, 2]. Weight control is considered
a cornerstone in primary prevention aimed at reducing
the overall incidence of cardiovascular disease. Obesity is
also frequently targeted in secondary preventive programs
intended to improve outcome in patients with already
established cardiovascular disease [3, 4]. One major problem
with standard strategies is that weight loss is diﬃcult to
achieve with conventional methods and the results are often
temporary.
Bariatric surgery has emerged as an eﬀective treat-
ment option to obtain large and sustained weight loss
in obese subjects [5]. Surgically induced weight loss has
been shown to improve or prevent many of the obesity-
related cardiovascular risk factors including hypertension,
dyslipidemia, diabetes, and obstructive sleep apnea [1, 2, 5–
9]. In addition, surgical intervention has been shown to
restrain the progression rate [10, 11] and in some cases
even reverse [12] the development of early atherosclerosis.
More recently, bariatric surgery has been demonstrated to
reduce overall and cardiovascular mortality when applied as
primary preventive strategy in morbid obesity [6].
Despite these encouraging ﬁndings, the use of bariatric
surgery in patients with established cardiovascular disease
has been limited. One probable explanation is the concern
about increased perioperative risk in this patient popula-
tion, but another reason could be the growing scepticism
towards weight control as a secondary preventive measure.
Uncertainty has arisen since several large epidemiological2 Journal of Obesity
studies have revealed an inverse relationship between BMI
and outcome in patients with ischemic heart disease [13].
An apparent “protective quality” of obesity has been demon-
strated in patients with acute coronary syndromes and those
undergoing coronary artery bypass grafting [14–16]. On the
otherhand,ithasbeenpointedoutthattheso-called“obesity
paradox” may just as well be related to adverse prognosis
in patients with disease-related cachexia. In any case, the
controversy remains and calls for controlled intervention
studies.
Bearing this in mind, the present study was aimed to
evaluate the safety and feasibility of bariatric surgery as a
preventivemeasureinobesesubjectswithischemicheartdis-
ease. This was performed by analysing data from the Swedish
Obese Subjects (SOS) controlled surgical intervention
trial.
2. Methods
2.1. The SOS Study. Brieﬂy, obese patients (BMI ≥ 38kg/m2
for women and BMI ≥ 34kg/m2 for men) between 37 and
60 years of age were assigned to either bariatric surgery or
conventional obesity treatment as described in earlier studies
[6]. Surgical intervention consisted of gastric banding, ver-
tical banded gastroplasty, or gastric bypass, whereas control
treatment involved conventional life style recommendations.
Exclusion criteria were minimal and allowed for a coronary
event outside 6 months of inclusion. The study complied
with the Declaration of Helsinki and was approved by the
regional boards for ethical approval.
2.2. Present Study Group. In the total SOS study cohort of
4047 subjects, 62 patients reported a history of myocardial
infarction at the time of screening. After evaluating ECG
recordings and hospital records, a prior coronary event
deﬁned as myocardial infarction, unstable angina, or prior
revascularization, could be veriﬁed in 37 of these subjects.
Two patients were excluded from the present report due to
early drop out, resulting in a ﬁnal study group of 35 subjects
(11 women and 24 men). Of these subjects, 21 underwent
bariatric surgery and 14 received conventional treatment.
Patients were evaluated at inclusion and again after 2 and 10
years.The averagefollow-upperiod was10.8 years(range 6.3
– 17.4 years). One subject declined two-year evaluation but
participated in the 10-year follow-up. Twenty-one patients
completed the 10-year follow-up (7 patients had died, 3
patients had not attained 10 years of follow-up, 3 patients
had withdrawn their consent, and 1 patient had emigrated).
2.3. Clinical and Laboratory Assessments. At each visit mea-
surements of body weight and height were obtained and
blood pressure recorded. Blood samples were drawn in
the morning after 10–12 hours of fasting. Blood glucose
and serum lipids were analysed by enzymatic techniques
(accredited according to European Norm 45001).
2.4. Cardiovascular Risk Factors. Hypertension was deﬁned
as systolic blood pressure ≥ 140mmHg or diastolic blood
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Figure 1: Mean weight change (%) at 2, 6, and 10 years of follow-
up in the surgery and control groups. Filled squares: surgery; Open
circles: controls. ∗∗∗P<. 001, ∗P<. 05.
pressure ≥ 90mmHg or treatment with antihypertensive
medication. Dyslipidemia was classiﬁed as total cholesterol
≥ 5.2mmol/L or triglycerides ≥ 2.8mmol/L or current lipid
lowering medication. The criteria for diabetes were fasting
glucose ≥ 6.1mmol/L or treatment with insulin or oral
hypoglycemic agents.
2.5. Cardiorespiratory Symptoms, Physical Activity, and Qual-
ity of Life. Patients completed a questionnaire at inclusion
and again after 2 and 10 years of follow-up. They were asked
about the occurrence of chest pain and breathlessness and
whether a family member or other person had observed
pauses in breathing during sleep. Subjects were also asked
to grade their level of physical activity during working and
leisure time and health related quality of life (HRQOL). The
HRQOL evaluation included questions regarding current
health perception, social interaction, obesity-related prob-
lems, overall mood, anxiety, and depression.
2.6. Adverse Events. Information regarding gastrointestinal
and cardiovascular adverse events was obtained from self-
administered questionnaires and veriﬁed by cross-checking
hospital records. A cardiovascular event was deﬁned as
hospitalisation or death due to cardiovascular disease.
Informationaboutperioperativecomplicationswasobtained
from surgical trial reports and discharge reports ﬁlled in by
the surgeon. Information on cause of death was acquired
from registries provided by the Swedish National Board of
Health Welfare.
2.7. Statistical Methods. Data are summarised as means
(±SD) for continuous variables and percentages for cate-
gorical data. Diﬀerences between groups and changes from
baseline were evaluated with paired ttests for continuous
variables, with Fisher’s exact test or McNemar’s test for
categorical variables, and with Pitman’s nonparametrical
test for quality of life data. Data on gastrointestinal and
cardiovascular adverse events, as well as mortality, are
presented in a descriptive manner.Journal of Obesity 3
Table 1: Anthropometrics and prevalence of cardiovascular risk factors (%) in the surgery and control groups at baseline and changes in
prevalence after 2 and 10 years of follow-up. Only the patients applicable for the certain timepoint are included in the statistical calculations.
Baseline Change at 2-year
follow-up
Change at 10-year
follow-up
Surgery n = 21 Surgery, n = 21 Surgery, n = 13
Control n = 14 Control, n = 13 Control, n = 8
Weight, kg
Surgery 122.8 ± 15 −26.3 ± 14.7∗∗∗ −17.3 ± 13.1∗
Control 115.3 ± 18 −2.3 ± 5.2 −4.3 ± 5.2
BMI, kg/m2
Surgery 40.6 ± 4.3 −8.6 ± 4.8∗∗∗ −5.6 ± 4.2∗
Control 38.0 ± 4.5 −0.8 ± 1.8 −1.5 ± 2.0
Waist circumference, cm
Surgery 128.3 ±8.3 −21.2 ±12.5 −12.9 ±12.2
Control 123.5±9.1 −12.9 ±12.2 −3.7 ± 6.0
Current smoker %
Surgery 52.4 −20.0∗ −18.2
Control 50.0 −14.8 −22.2
Hypertension %
Surgery 57.1 −15.0∗∗∗ −23.1∗
Control 53.8 21.2 0
Dyslipidemia %
Surgery 95.2 −28.5∗∗∗ −69.2
Control 92.9 0 −22.2
Diabetes %
Surgery 52.4 −14.3∗∗∗ −7.7∗∗∗
Control 50.0 0 11.1
P-value denotes diﬀerences in eﬀects of treatment between the two groups from baseline to 2 and 10 years of follow-up. ∗P< . 05, ∗∗∗P< . 001.
3. Results
3.1. Demographics. At baseline, the surgery group (n =
21) and control group (n = 14) were comparable with
respect to age (50.9 ± 5.7 versus 53.2 ± 4.9 years), gender
distribution (33% versus 40% females), and body weight
(122 ± 15 versus 115 ± 18kg).
Bariatric surgery resulted in sustained weight loss after 2
and 10 years (surgery: 21.2% after 2 years and −13.8% after
10 years, controls: -2.4% after 2 years and −13.8% after 10
years, P<. 001) (Figure 1). Changes in body weight, BMI,
and waist circumference are shown in Table 1.
3.2. Cardiovascular Risk Factors. At baseline, the prevalence
of hypertension, dyslipidemia, and diabetes was similar in
the two study groups. After 2 years, the surgery group
displayed signiﬁcant improvements in all of these cardiovas-
cular risk factors as compared to control subjects. After 10
years,recoveryfromhypertensionanddiabeteswasstillmore
prevalent among surgically treated patients (Table 1).
3.3. Cardiorespiratory Symptoms and Physical Activity. At
baseline, the prevalence of sleep disordered breathing was
similar in the two study groups, whereas the surgery group
reported lower frequencies of chest pain, breathlessness, and
a higher degree of physical inactivity. After two years of
follow-up, surgical patients displayed signiﬁcant improve-
ments in all 4 conditions, as compared with control subjects.
After 10 years, a reversal of physical inactivity was still more
common in the surgery group (Table 2).
3.4. Health-Related Quality of Life. HRQOL was similar in
both study groups at baseline, except for obesity-related
problems, which were reported more often in the surgery
group.After2years,thesurgerygroupdisplayeddiminutions
in obesity-related problems and improvements in social
interaction and depression score, as compared with controls.
After 10 years, recovery from depression and obesity-related
problems was still more frequent in the surgery group
(Table 3).
3.5. Adverse Events. In patients who underwent bariatric
surgery there were no postoperative deaths. One patient
bled 1300 mL during surgery. Otherwise there were no peri-
operative complications reported. Frequent adverse events
included nausea and/or abdominal pain, which lead to
unscheduled gastroscopy in 12 patients (57%). Serious
adverse events, requiring surgical or endoscopic treatment,4 Journal of Obesity
Table 2: Chest pain, breathlessness sleep apnea, and physical activity (%) in the surgery and control groups at baseline and changes in
prevalence after 2 and 10 years of follow-up. Only the patients applicable for the certain timepoint are included in the statistical calculations.
Baseline Change at 2-year
follow-up
Change at 10-year
follow-up
Surgery n = 21 Surgery, n = 21 Surgery, n = 13
Control n = 14 Control, n = 13 Control, n = 8
Chest pain %
Surgery 38.1 −18.1∗∗∗ −36.4
Control 84.6 −7.7 −33.3
Breathlessness %
Surgery 61.9 −51.9∗∗ −45.4
Control 84.6 23.1 25
Sleep apnea %
Surgery 52.4 −42.1∗∗∗ −54.5
Control 53.8 0 −66.7
Physical inactivity %
Surgery 47.6 −12.6∗∗∗ −18.2∗∗
Control 30.8 23.0 11.1
P-value denotes diﬀerences in eﬀects of treatment between the two groups from baseline to 2 and 10 years of follow-up. ∗∗P< . 01, ∗∗∗P< . 001.
Table 3: Health related quality of life in surgery and control groups at baseline and changes in prevalence after 2 and 10 years of follow-up.
Only the patients applicable for the certain timepoint are included in the statistical calculations.
Baseline Change at 2-year
follow-up
Change at 10-year
follow-up
Surgery, n = 21 Surgery, n = 21 Surgery, n = 13
Control, n = 14 Control, n = 13 Control, n = 8
Current health perceptions
Surgery 41.3 ± 19.8 21.8 ± 30.3 −0.8 ± 14.5
Control 35.1 ± 24.2 6.6 ± 16.2 6.8 ± 29.3
Social interaction
Surgery 15.5 ± 15.6 −9.9 ± 12.6∗ −3.4 ± 8.9
Control 15.8 ± 11.1 0.4 ± 9.9 −9.7 ± 12.0
Obesity-related Problems scale
Surgery 48.4 ± 31.3 −35.1 ± 26.5∗∗∗ −31.0 ±26.7
∗∗
Control 28.3 ± 27.7 8.7 ± 19.6 −0.8 ± 14.6
Overall Mood
Surgery 2.85 ± 0.52 0.23 ± 0.41 0.09 ± 0.34
Control 2.79 ± 0.63 −0.01 ± 0.55 0.18 ± 0.32
Anxiety
Surgery 6.5 ± 4.4 −1.7 ± 3.5 −1.2 ± 2.8
Control 7.5 ± 4.8 −1.0 ± 2.7 −2.4 ± 4.2
Depression
Surgery 5.2 ± 2.8 −1.9 ± 2.7∗ −0.7 ± 2.6
∗
Control 5.1 ± 2.7 0.5 ± 2.2 0.1 ± 2.8
P-value denotes diﬀerences in eﬀects of treatment between the two groups from baseline to 2 and 10 years of follow-up.∗P< . 05, ∗∗P< . 01, ∗∗∗P< . 001.
Current health perceptions: scale range 0–100; high scores represent well-being.
Social interaction: scale range and obesity-related problems scale 0–100; high scores indicate dysfunction.
Overall mood: scale range 1–4; high scores represent well-being.
Anxiety and depression: scale range 0–21; high scores represent symptoms.Journal of Obesity 5
occurred in 3 patients (14%) and consisted of pouch stenosis
(1), pouch dilatation (1), and incisional hernia (1). No
signiﬁcant diﬀerences were observed between the surgery
and control groups with respect to cardiovascular event
rates, including myocardial infarction (42.9% versus 38.5%)
coronary revascularisation (47.6% versus 53.8%) and total
cardiovascular events (61.9% versus 69.2%). Mean time to
ﬁrst event was 5.7 years in the surgery group and 5.5 years
in the control group. During the follow-up period 6 patients
(29%)inthesurgerygroupdied,ascomparedwith5patients
(38.5%) in the control group. The most common cause of
death was cardiovascular (66.7% versus 80%).
4. Discussion
The eﬀect that obesity and weight loss have on secondary
outcomes in ischemic heart disease remains unclear. Con-
trary to intuition, many studies report a protective eﬀect
of obesity on prognosis in IHD populations [13]. This
“obesity paradox” has been described for acute coronary
syndromes [17, 18], percutaneous coronary intervention
[14, 16], and coronary artery bypass grafting [15]. In view
of these ﬁndings, the present recommendations of weight
control in patients with coronary heart disease have been
questioned.
Even though, in small cohorts, we and others [2, 19]n o w
provide data indicating that bariatric surgery can be a safe
method to attain sustained weight loss also for obese subjects
with established IHD, among patients treated with surgery
there were no signs of increased short-term or long-term
cardiovascularmorbidityormortality.Postoperativecompli-
cations were comparable with those previously reported in
obese patients free from cardiovascular disease.
The beneﬁcial eﬀects of bariatric surgery in the present
study were in line with those previously observed [6, 8, 20,
21]. After two years, surgically induced weight loss was asso-
ciated with favourable eﬀects on multiple cardiovascular risk
factors, including abdominal obesity, hypertension, diabetes,
and dyslipidemia. Patients also experienced a signiﬁcant
relief from symptoms of chest pain and breathlessness and
reduction in sleep-disordered breathing. Physical activity
during leisure time increased and several aspects of quality
of life improved. After 10 years, recovery from hypertension,
diabetes, physical inactivity, and depression was still more
common in treated patients.
In view of the ﬁndings in the present study, previous
concerns about increased perioperative risk associated with
bariatric surgery appear to be unwarranted. Further, the
widespread eﬀects of surgical obesity treatment on symp-
toms and risk factors make it an attractive alternative in
attaining secondary prevention in patients with ischemic
heart disease. Still, risk factor improvements following
bariatric surgery did not translate into reduced clinical
endpoints when surgery and control groups were compared.
It is possible that the small study sample precluded the
detection of an actual diﬀerence in event rate between the
two study groups and larger cohort studies are needed to
elucidate the eﬀect of bariatric surgery on clinical outcome.
The main limitation of the present study is its small
sample size, which precluded any ﬁrm conclusions with
respect to cardiovascular outcome. Its strength, on the
other hand, is the long-term follow-up of prospectively
collecteddata,whichmakesitreasonabletoconcludethatthe
operative procedure is safe in patients with ischemic heart
disease. Another weakness is the nonrandomized design of
the study. Despite this, the two groups were quite similar
with respect to baseline demographics. Thereby the conclu-
sions with respect to improvements in cardiovascular risk
factors, symptoms, and quality of life following surgery seem
valid.
In this study most patient were treated with minimal
invasive surgery techniques with a known low complication
rate (gastric banding or vertical banded gastroplasty). In
studies using gastric bypass as surgical method a higher peri-
and postoperative complication rate could be expected.
5. Conclusion
Taken together we have provided data that support the
safety and feasibility of bariatric surgery in obese patients
with IHD. This is encouraging for future-controlled studies
prospectively evaluating the long-term eﬀects of bariatric
surgery in this patient population. Future trials should aim
to explore bariatric surgery in obese patients with IHD and
metabolic complications.
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